Hoffmann, Christopher J.Herce, Michael E.Chimoyi, LucySmith, Helene J.Tlali, MphoOlivier, Cobus J.Topp, Stephanie M.Muyoyeta, MondeReid, Stewart E.Hausler, HarryCharalambous, SalomeFielding, Katherine2024-09-052024-08Hoffmann, C.J., Herce, M.E., Chimoyi, L. et al. 2024, 'Reaching for 90:90:90 in correctional facilities in South Africa and Zambia: virtual cross-section of coverage of HIV testing and antiretroviral therapy during universal test and treat implementation', Journal of Acquired Immune Deficiency Syndromes, vol. 96, no. 5, pp. 465-471, doi : 10.1097/QAI.0000000000003456.1525-4135 (print)1077-9450 (online)10.1097/QAI.0000000000003456http://hdl.handle.net/2263/98025DATA SHARING : All deidentified matched correctional facility and HIV-related continuum data along with a data dictionary will be made available on request from the corresponding author.BACKGROUND : People in correctional settings are a key population for HIV epidemic control. We sought to demonstrate scale-up of universal test and treat in correctional facilities in South Africa and Zambia through a virtual cross-sectional analysis. METHODS : We used routine data on 2 dates: At the start of universal test and treat implementation (time 1, T1) and 1 year later (time 2, T2). We obtained correctional facility census lists for the selected dates and matched HIV testing and treatment data to generate virtual cross-sections of HIV care continuum indicators. RESULTS : In the South African site, there were 4193 and 3868 people in the facility at times T1 and T2; 43% and 36% were matched with HIV testing or treatment data, respectively. At T1 and T2, respectively, 1803 (43%) and 1386 (36%) had known HIV status, 804 (19%) and 845 (21%) were known to be living with HIV, and 60% and 56% of those with known HIV were receiving antiretroviral therapy (ART). In the Zambian site, there were 1467 and 1366 people in the facility at times T1 and T2; 58% and 92% were matched with HIV testing or treatment data, respectively. At T1 and T2, respectively, 857 (59%) and 1263 (92%) had known HIV status, 277 (19%) and 647 (47%) were known to be living with HIV, and 68% and 68% of those with known HIV were receiving ART. CONCLUSIONS : This virtual cross-sectional analysis identified gaps in HIV testing coverage, and ART initiation that was not clearly demonstrated by prior cohort-based studies.en© 2024 Wolters Kluwer Health, Inc. All rights reserved. This is a non-final version of an article published in final form in Journal of Acquired Immune Deficiency Syndromes, vol. 96, no. 5, pp. 465-471, 2024, doi : 10.1097/QAI.0000000000003456.Correctional facilitiesSouth Africa (SA)ZambiaHuman immunodeficiency virus (HIV)HIV epidemic controlAntiretroviral therapy (ART)Cross-sectional analysisSDG-03: Good health and well-beingHealth sciences articles SDG-03SDG-03: Good health and well-beingHealth sciences articles SDG-10SDG-10: Reduced inequalitiesHealth sciences articles SDG-16SDG-16: Peace, justice and strong institutionsHealth sciences articles SDG-17SDG-17: Partnerships for the goalsPostprint Article